US Patent Issued to St. Jude Medical Cardiology Division on May 6 for "Candidate screening for a target therapy" (German Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,293,839, issued on May 6, was assigned to St. Jude Medical Cardiology Division Inc. (St. Paul, Minn.).

"Candidate screening for a target therapy" was invented by Lars Holdmann (Wettenberg, Germany) and Jannis Radeleff (Frankfurt, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Techniques are provided for candidate screening for a target therapy. A plurality of medical codes corresponding to patient billing data are identified. A candidate classification model for a target therapy is generated by selecting a set of medical codes from the plurality of medical codes and assigning a weight to each medical code selected. The candidate classification m...